Muscle injuries in athletics during the 2020 Tokyo Olympic Games: differences between heats and finals

BACKGROUND

The aim of this study was to analyze muscle injuries and their related risk factors during the Athletics events of the 2020 Tokyo Olympic Games including the differences in muscle injury rates between heats and finals.

METHODS

We included and analyzed in this study muscle injuries diagnosed by either magnetic resonance imaging, ultrasound, or physical examinations by at least two physicians, from Athletics athletes participating at the 2020 Tokyo Olympic Games. Data from electronic medical records, including sex, nationality, event, and the round (heat vs. final) during which the muscle injury occurred and the air temperature in the stadium, measured every five minutes during the competition were extracted.

RESULTS

Among the 1631 athletes who competed, a total of 36 athletes (20 males and 16 females) were diagnosed with a muscle injury during the 2020 Tokyo Olympic Games. Among them, 24 occurred during heats (1.47 per 100 athletes) and 12 during finals (2.20 per 100 athletes) (P=0.25). Logistic regression analysis revealed that the geographic region of athletes' origin was a factor associated with muscle injury, with the highest muscle injury rate being in athletes from Africa (odds ratio [OR]=4.74, 95% confidence interval [CI]) = 1.75 to 12.82) and North America (OR=3.02, 95%CI=1.27 to 7.20). For male athletes, competing in finals was a risk factor to sustain a muscle injury (OR=2.55, 95%CI=1.01 to 6.45).

CONCLUSIONS

During the 2020 Olympic Games, muscle injury rate was higher in finals than in heats, reaching statistical significance in male athletes.

Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions: Part 1: Supraventricular arrhythmias. A position statement of the Section of Sports Cardiology and Exercise from the European Association of Preventive Cardiology (EAPC) and the European Heart Rhythm Association (EHRA), both associations of the European Society of Cardiology

Symptoms attributable to arrhythmias are frequently encountered in clinical practice. Cardiologists and sport physicians are required to identify high-risk individuals harbouring such conditions and provide appropriate advice regarding participation in regular exercise programmes and competitive sport. The three aspects that need to be considered are: (a) the risk of life-threatening arrhythmias by participating in sports; (b) control of symptoms due to arrhythmias that are not life-threatening but may hamper performance and/or reduce the quality of life; and (c) the impact of sports on the natural progression of the underlying arrhythmogenic condition. In many cases, there is no unequivocal answer to each aspect and therefore an open discussion with the athlete is necessary, in order to reach a balanced decision. In 2006 the Sports Cardiology and Exercise Section of the European Association of Preventive Cardiology published recommendations for participation in leisure-time physical activity and competitive sport in individuals with arrhythmias and potentially arrhythmogenic conditions. More than a decade on, these recommendations are partly obsolete given the evolving knowledge of the diagnosis, management and treatment of these conditions. The present document presents a combined effort by the Sports Cardiology and Exercise Section of the European Association of Preventive Cardiology and the European Heart Rhythm Association to offer a comprehensive overview of the most updated recommendations for practising cardiologists and sport physicians managing athletes with supraventricular arrhythmias, and provides pragmatic advice for safe participation in recreational physical activities, as well as competitive sport at amateur and professional level. A companion text on recommendations in athletes with ventricular arrhythmias, inherited arrhythmogenic conditions, pacemakers and implantable defibrillators is published as Part 2 in Europace.

The innovative role of Olympic sports and exercise in the promotion of health, gender equality and sustainability: past achievements and future challenges

Olympic sports represent, through their athletes, an iconic source of inspiration and ambition for everyone. During every Olympiad we are reminded of the astonishing achievements that can be reached through hard work and dedication. Nevertheless, these performances are very far from the reality of those being physically active to improve their health and fitness. The technological development that humanity has gone through in the last couple of centuries, has engineered physical activity out of our lives and dramatically altered our lifestyle, leading to the development of diseases that were not so prevalent. Exercise has become an integral part of our lives and it is now regarded as a medicine to prevent and counteract chronic conditions that are associated with a sedentary lifestyle. In this context Olympic sports can play a key role in attracting people to be physically active as well as leveraging on city governments to allow, not only sport participation, but a global active lifestyle. Therefore, International Sports Federations (ISF) have a central position in ensuring sports are in line with the changes occurring in society as well as fostering its natural evolution. Examples of this evolution are gender equality and sustainability, topics that finally are becoming central in ISFs as they have been in society for decades. Therefore, Olympic sports should acknowledge the prominent role they have in society and contribute to its further development by promoting socially relevant actions.

Brief recommendations for participation in competitive sports of athletes with arterial hypertension: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)

Owing to its undisputed multitude of beneficial effects, European Society of Cardiology guidelines advocate regular physical activity as a class IA recommendation for the prevention and treatment of cardiovascular disease. Nonetheless, competitive athletes with arterial hypertension may be exposed to an increased risk of cardiovascular events. Guidance to physicians will be given in this summary of our recently published recommendations for participation in competitive sports of athletes with arterial hypertension.

Medical encounters (including injury and illness) at mass community-based endurance sports events: an international consensus statement on definitions and methods of data recording and reporting

Mass participation endurance sports events are popular but a large number of participants are older and may be at risk of medical complications during events. Medical encounters (defined fully in the statement) include those traditionally considered 'musculoskeletal' (eg, strains) and those due to 'illness' (eg, cardiac, respiratory, endocrine). The rate of sudden death during mass endurance events (running, cycling and triathlon) is between 0.4 and 3.3 per 100 000 entrants. The rate of other serious medical encounters (eg, exertional heat stroke, hyponatraemia) is rarely reported; in runners it can be up to 100 times higher than that of sudden death, that is, between 16 and 155 per 100 000 race entrants. This consensus statement has two goals. It (1) defines terms for injury and illness-related medical encounters, severity and timing of medical encounters, and diagnostic categories of medical encounters, and (2) describes the methods for recording data at mass participation endurance sports events and reporting results to authorities and for publication. This unifying consensus statement will allow data from various events to be compared and aggregated. This will inform athlete/patient management, and thus make endurance events safer.

The role of physical activity in the prevention and treatment of chronic diseases

The aim of this review is to assess the current evidence in scientific literature that supports the use of physical activity as a fundamental tool for primary and secondary prevention and to encourage its use conscientiously. Observational studies and international guidelines have been examined to evaluate the positive effects of physical activity as primary prevention on some of the most common diseases. We have also evaluated those studies which demonstrate that the association of physical activity with drug therapy in chronic diseases results in a better prognosis. We researched the Cochrane Controlled Trials Register, MEDLINE, PubMed up to January 2009. Furthermore, we screened references in relevant reviews and clinical trials. Sixty four studies were included in the review and cited as giving consistent evidence for the utilization of physical activity to improve health. There is strong evidence that, according to international guidelines, physical activity should be adopted as a tool in the prevention and treatment of many chronic diseases.